Results 111 to 120 of about 130,584 (225)
Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies. [PDF]
Rozengurt E, Eibl G.
europepmc +1 more source
Rare Association Between Neurofibromatosis Type 1 and Adrenocortical Carcinoma
Axial slice CT abdomen pelvis with portal venous contrast, revealing a well circumscribed 22 × 20 × 22 mm left adrenocortical adenocarcinoma (ACC) in a patient with neurofibromatosis type 1 (NF1). ABSTRACT Although rare, adrenocortical carcinoma (ACC) should be considered in individuals with neurofibromatosis type 1 (NF1) presenting with adrenal ...
Zachary Pluim +6 more
wiley +1 more source
Immuno-neural mechanisms in gastrointestinal tumorigenesis: bridging inflammation, neural regulation, and therapeutic innovation. [PDF]
Zhao Y +7 more
europepmc +1 more source
Glymphatic System Dysfunction in Central Nervous System Diseases
Glymphatic Dysfunction in Neurological Disorders: The glymphatic system is a brain‐wide clearance system that removes neurotoxic waste via AQP4‐mediated CSF‐ISF exchange. Dysfunction through AQP4 mislocalization, BBB injury, and inflammation annihilates clearance and causes acute (stroke, TBI) and chronic disease.
Anwar Zahran +14 more
wiley +1 more source
Role of the neurotransmitter-receptor pathway in T-cell tumor immunology and cancer immunotherapy. [PDF]
Fan M, Zhao X.
europepmc +1 more source
Abstract This single‐center, randomized, open‐label bioequivalence program compared two fixed‐dose combination (FDC) tablets containing ibuprofen (200 mg) and phenylephrine hydrochloride (10 mg) from different manufacturers in healthy Chinese adults under fasting and fed conditions. A three‐period, partially replicated crossover design was used for the
Menghan Ye +8 more
wiley +1 more source
Utility of inhaled β2-agonists in reducing serum potassium levels in adult patients with hyperkalemia: A scoping review. [PDF]
Arzayus-Patiño L +4 more
europepmc +1 more source
ABSTRACT Objective To compare the efficacy and safety of lisdexamfetamine, topiramate, and naltrexone/bupropion for treating binge eating disorder (BED) using network meta‐analysis. Method We systematically searched PubMed, Scopus, ClinicalTrials.gov, and Cochrane Central up to February 2025 for randomized controlled trials evaluating these medications
Tamer Hodrob +5 more
wiley +1 more source

